Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3551089 | 0.88 | — | — | |
| SCHEMBL12870189 | 0.88 | — | — | |
| SCHEMBL18412739 | 0.88 | — | — | |
| SCHEMBL24279166 | 0.87 | ALDH1A1 (0.33) | ALDH1A1KDM4ECYP2D6HPGDHTT | |
| SCHEMBL21129089 | 0.87 | ALDH1A1 (0.33) | ALDH1A1KDM4ECYP2D6HPGDHTT | |
| SCHEMBL24279174 | 0.87 | ALDH1A1 (0.33) | ALDH1A1KDM4ECYP2D6HPGDHTT | |
| SCHEMBL3435730 | 0.78 | — | — | |
| SCHEMBL75912 | 0.78 | — | — | |
| SCHEMBL3435692 | 0.78 | — | — | |
| SCHEMBL24239378 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110621653-B | Amino (meth) acrylates | 湛新比利时股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| US-11318120-B2 | Nuclear transport modulators and uses thereof | BIOGEN MA INC. (US) | 2022-05-03 | — | — | US | disclosed |
| US-20210251968-A1 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | BIOGEN MA INC. (US) | 2021-08-19 | — | — | US | disclosed |
| EP-2032115-B1 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS BV (NL) | 2021-07-21 | — | — | EP | disclosed |
| CN-110621653-A | Amino (meth) acrylates | 湛新比利时股份有限公司 | 2019-12-27 | — | — | CN | disclosed |
| EP-1991604-B1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSM IP ASSETS BV (NL) | 2018-03-28 | — | — | EP | disclosed |
| EP-2454312-B1 | RESINS AND COATING COMPOSITIONS | DSM IP ASSETS BV (NL) | 2017-03-01 | — | — | EP | disclosed |
| US-8999494-B2 | Resins and coating compositions | DSM IP ASSETS B.V. (NL) | 2015-04-07 | — | — | US | disclosed |
| US-8951509-B2 | Heterocyclic substituted condensation polymers | DSM IP ASSETS B.V. (NL) | 2015-02-10 | — | — | US | disclosed |
| US-8394500-B2 | Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers | DSM IP ASSETS B.V. (NL) | 2013-03-12 | — | — | US | disclosed |
| WO-2007144189-A2 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007098889-A1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2007-09-07 | — | — | WO | disclosed |
| US-6730771-B2 | THERMOPLASTIC, THERMOSETTING RESINS | DSM N.V. (NL) | 2004-05-04 | — | — | US | disclosed |
| EP-1171510-B1 | CONDENSATION POLYMER CONTAINING DIALKYLAMIDE ENDGROUPS, PROCESS FOR PRODUCING SAID CONDENSATION POLYMERS AND APPLICATIONS THEREOF | DSM IP ASSETS BV (NL) | 2003-11-05 | — | — | EP | disclosed |
| US-6541110-B2 | Endcapped polyamideester copolymers; compatible blend with another polymer | DSM N.V. (NL) | 2003-04-01 | — | — | US | disclosed |
| US-20020137880-A1 | Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof | DSM IP ASSETS B.V. (NL) | 2002-09-26 | — | — | US | disclosed |
| US-20020019509-A1 | Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof | DSM N.V. (NL) | 2002-02-14 | — | — | US | disclosed |
| EP-1171510-A1 | CONDENSATION POLYMER CONTAINING DIALKYLAMIDE ENDGROUPS, PROCESS FOR PRODUCING SAID CONDENSATION POLYMERS AND APPLICATIONS THEREOF | DSM N.V. (NL) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000058388-A1 | CONDENSATION POLYMER CONTAINING DIALKYLAMIDE ENDGROUPS, PROCESS FOR PRODUCING SAID CONDENSATION POLYMERS AND APPLICATIONS THEREOF | DSM N.V. (NL) | 2000-10-05 | — | — | WO | disclosed |
| EP-1038902-A1 | Condensation polymers containing dialkylamide endgroups, process for their production and applications thereof | DSM N.V. (NL) | 2000-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210251968-A1 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | XPO1, XPO5, XPOT | ALDH1A1 3151/4885KDM4E 2315/4885CYP2D6 1762/4885 |
| US-11318120-B2 | Nuclear transport modulators and uses thereof | XPO1, XPO5, XPOT | ALDH1A1 3151/4885KDM4E 2315/4885CYP2D6 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.